TREAT Asia
TREAT Asia (Therapeutics Research, Education, and AIDS Training in Asia) is a network of clinics, hospitals, and research institutions working with civil society to ensure the safe and effective delivery of HIV/AIDS treatments throughout Asia and the Pacific. Facilitated by amfAR – the Foundation for AIDS Research - TREAT Asia seeks to strengthen HIV/AIDS care, treatment, and management skills among health care professionals through education and training programs developed by experts in the region. Within the LAASER HIV/AIDS program, TREAT Asia is the implementing partner for the HAART resistance monitoring and surveillance project in Asia (TASER).
TREAT Asia Studies to Evaluate Resistance (TASER)
TREAT Asia Studies to Evaluate Resistance (TASER) enables regional capacity building on laboratory testing, clinical monitoring of acquired and transmitted HIV drug resistance in up to 10 countries across south, east and southeast Asia. TASER consists of four integral components:
- HIV drug resistance monitoring; prospective cohort studies in patients on HAART in selected clinical sites;
- HIV drug resistance surveillance; cross-sectional surveys to evaluate resistance transmission;
- Quality Assurance Laboratory Network;
- Clinical Observational Database (to effectively inform clinicians, publich health specialists and policy makers on optimal ART program practices and guidelines)
For more information about TREAT Asia and its role within the LAASER HIV/AIDS program, visit www.treatasia.org or contact Liesl Messerschmidt.